Marsing to market
products of 6 Indian Pharma Cos in Europe
Posted AtNew
Kerala
Bangalore: Denmark-based Pharmaceutical
marketing and distributing company, Marsing, will take
up marketing of products of six major Indian Pharma
Companies in Europe, besides Hikal, which had a majority
stake in it.
Marsing Chairman Jai Hiremath, also the Vice-Chairman
and Managing Director of Hikal Ltd, told newspersons
here that Marsing had made good progress in getting
regulatory approvals for Hikal's Active Pharmaceutical
Ingredients (APIs) in Europe and was in advanced discussions
with other Indian Pharmaceutical companies to distribute
their APIs, hospital injectables and veterinary formulations
in the European market.
January 24, 2006
Full
Story
Top 10 predictions for Indian
IT in 2006
Posted AtRediff.com
India will be the fastest growing IT
market in the Asia Pacific region with its domestic
IT market set to grow at an estimated 19% in 2006 over
2005, according to IT and telecom consulting major IDC.
"Year 2006 will be governed by the underlying themes
of mobility, convergence and infrastructure management,"
said Kapil Dev Singh, country manager, IDC (India) Ltd.
Dynamic IT in the enterprise space and increasing proliferation
of digital devices in the consumer space, will drive
the growth of IT market in 2006.
January 24, 2006
Full
Story
New India pharmacopoeia by
year end
Posted AtThe
Financial Express
The Indian Pharmacopoeia Commission (IPC)
is planning to bring out a new edition of the Indian
pharmacopoeia (IP), a set of reference standards that
govern the manufacture of drugs in the country, by end
2006.
The current edition of IP was published in 1996, and
the industry had been demanding that the IP be revised
to include new developments in the pharmaceuticals sphere.
Speaking at the 9th IDMA-Pharmaceutical Analystsâ
Convention 2006 here on Monday, Dr GN Singh, Sec-.cum-Sci.
director, IPC, also said that 50 reference standards
will be included in the new edition in the first year,
followed by 250 in course of time.
January 24, 2006
Full
Story
Stock Watch
Posted AtExpress
Pharm
The year 2005 saw a host of Indian pharma
companies in deal with foreign firms. Mergers, acquisitions
and strategic alliances were the order of the day. With
contract research and manufacturing services (CRAMS)
opening doors to Indian pharma, domestic pharmaceutical
exports are expected to grow by 30 percent, touching
a new high of Rs 21,685 crore this financial year.
The year 2006 will continue to see large number of global
pharmaceutical majors outsourcing the manufacturing
activity to Indian pharma companies, which enjoy much
lower costs than their western counterparts.On the policy
front, the government has proposed reduction of excise
duty on all pharma products from 16 percent to eight
percent. This will be favourable for pharma companies
that have a major chunk of their turnover coming from
the domestic market.
January 24, 2006
Full
Story |
